Literature DB >> 10350001

The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis.

F Reymond1, G Steyaert, P A Carrupt, D Morin, J P Tillement, H H Girault, B Testa.   

Abstract

PURPOSE: The anti-ischemic drug trimetazidine (TMZ) acts by a combination of molecular mechanisms which begin to be understood. Thus, it acts in the micromolar range to significantly reduce intracellular acidification during ischemia. To search for a possible physicochemical explanation of this phenomenon, we investigated the transfer mechanisms of the various electrical forms of this dibasic drug.
METHODS: The transfer characteristics of TMZ were studied by electrochemistry at the water/1,2-dichloroethane interface. Cyclic voltammetry was used to measure the formal transfer potentials of singly and doubly protonated forms of TMZ (noted TH+ and TH(2)2+, respectively) as a function of aqueous pH, and the partition coefficient of neutral TMZ (log P(T)) was measured by two-phase titration.
RESULTS: log P(T) was measured to be 1.04 +/- 0.06, and the acid-base dissociation constants in water were deduced to be pK(w)a1 = 4.54 +/- .02 and pK(w)a2 = 9.14 +/- 0.02. The partition coefficients of TH+ and TH(2)2+ were found to be respectively log P0'TH+ = -3.78 +/- 0.16 and log P0'TH(2)2+ = -9.84 +/- 0.30, which agrees well with the charge being delocalized on two nitrogen atoms in TH+. The pH-partition profile of TMZ was then established in the form of its ionic partition diagram, which showed that the affinity of the ions for the organic phase is pH-dependent and strongly increased by the interfacial potential.
CONCLUSIONS: This behavior suggests a physicochemical mechanism whereby efflux of protonated TMZ out of an acidified cell is facilitated, in effect exporting protons to extracellular space.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350001     DOI: 10.1023/a:1018899802836

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Lipophilicity Profiles of Ampholytes.

Authors:  Alessandra Pagliara; Pierre-Alain Carrupt; Giulia Caron; Patrick Gaillard; Bernard Testa
Journal:  Chem Rev       Date:  1997-12-18       Impact factor: 60.622

Review 2.  Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics.

Authors:  D A Smith; B C Jones; D K Walker
Journal:  Med Res Rev       Date:  1996-05       Impact factor: 12.944

3.  Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore.

Authors:  D Morin; A Elimadi; R Sapena; A Crevat; P A Carrupt; B Testa; J P Tillement
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

Review 4.  Keilin's respiratory chain concept and its chemiosmotic consequences.

Authors:  P Mitchell
Journal:  Science       Date:  1979-12-07       Impact factor: 47.728

5.  Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte.

Authors:  D Lagadic-Gossmann; K Le Prigent; D Feuvray
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  Trimetazidine reverses calcium accumulation and impairment of phosphorylation induced by cyclosporine A in isolated rat liver mitochondria.

Authors:  M D Salducci; A M Chauvet-Monges; J P Tillement; E Albengres; B Testa; P Carrupt; A Crevat
Journal:  J Pharmacol Exp Ther       Date:  1996-04       Impact factor: 4.030

  6 in total
  4 in total

Review 1.  New strategies to optimize kidney recovery and preservation in transplantation.

Authors:  Delphine Bon; Nicolas Chatauret; Sébastien Giraud; Raphael Thuillier; Frédéric Favreau; Thierry Hauet
Journal:  Nat Rev Nephrol       Date:  2012-05-01       Impact factor: 28.314

2.  Protective effects of trimetazidine on bone marrow mesenchymal stem cells viability in an ex vivo model of hypoxia and in vivo model of locally myocardial ischemia.

Authors:  Hongxin Xu; Gangyan Zhu; Yihao Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

3.  [(3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance.

Authors:  D Morin; R Sapena; A Elimadi; B Testa; S Labidalle; A Le Ridant; J P Tillement
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Antipsychotic-like effect of trimetazidine in a rodent model.

Authors:  Oytun Erbaş; Hüseyin Serdar Akseki; Betül Eliküçük; Dilek Taşkıran
Journal:  ScientificWorldJournal       Date:  2013-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.